Sugi Predict

Sugi Predict / Compounds / SCHEMBL10250453

SCHEMBL10250453

SCHEMBL10250453

CCOC(=O)CCCCCCC(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.53
▸ GAA P10253 2/20 0.52
▸ ALDH1A1 P00352 3/20 0.49
▸ ALOX15 P16050 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ TSHR P16473 2/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ DGKA P23743 1/20 0.48
▸ CYP4F2 P78329 2/20 0.46
▸ CYP4A11 Q02928 2/20 0.46
▸ TRPA1 O75762 1/20 0.45
▸ PAM P19021 2/20 0.44
▸ USP2 O75604 1/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ NR1I2 O75469 1/20 0.43
▸ PGR P06401 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ PTGS2 P35354 1/20 0.43
▸ PDE4D Q08499 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15183507 1.00 CYP1A2 (0.53) CYP1A2GAAALDH1A1ALOX15TDP1
SCHEMBL12933282 1.00 CYP1A2 (0.53) CYP1A2GAAALDH1A1ALOX15TDP1
SCHEMBL15183505 1.00 CYP1A2 (0.53) CYP1A2GAAALDH1A1ALOX15TDP1
SCHEMBL15183506 1.00 CYP1A2 (0.53) CYP1A2GAAALDH1A1ALOX15TDP1
SCHEMBL1908800 0.98 CYP1A2 (0.55) CYP1A2GAAALDH1A1ALOX15TDP1
SCHEMBL8165697 0.92 CYP1A2 (0.57) CYP1A2GAAALDH1A1ALOX15TDP1
SCHEMBL10081248 0.90 ALDH1A1 (0.65) CYP1A2GAAALDH1A1ALOX15TDP1
SCHEMBL27940048 0.86 CYP1A2 (0.52) CYP1A2GAAALDH1A1ALOX15TDP1
SCHEMBL27940125 0.86 CYP1A2 (0.52) CYP1A2GAAALDH1A1ALOX15TDP1
SCHEMBL10081247 0.86 ALDH1A1 (0.48) CYP1A2GAAALDH1A1ALOX15TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114410191-B Low-VOC quick-drying epoxy ester dip-coating primer and preparation method thereof 浙江天女集团制漆有限公司 2023-05-02 — — CN claimed
CN-114410191-A Low-VOC quick-drying epoxy ester dip-coating primer and preparation method thereof 浙江天女集团制漆有限公司 2022-04-29 — — CN claimed
CN-114410191-B Low-VOC quick-drying epoxy ester dip-coating primer and preparation method thereof 浙江天女集团制漆有限公司 2023-05-02 — — CN disclosed
CN-114410191-A Low-VOC quick-drying epoxy ester dip-coating primer and preparation method thereof 浙江天女集团制漆有限公司 2022-04-29 — — CN disclosed
US-10647747-B2 Cyclosporin derivatives and uses thereof S&T GLOBAL INC. (US) 2020-05-12 — — US disclosed
US-20180105558-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. 2018-04-19 — — US disclosed
US-20180105558-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. 2018-04-19 — — US disclosed
US-9890198-B2 Cyclosporin derivatives and uses thereof S&T GLOBAL INC. (US) 2018-02-13 — — US disclosed
US-9890198-B2 Cyclosporin derivatives and uses thereof S&T GLOBAL INC. (US) 2018-02-13 — — US disclosed
US-9604981-B2 IP receptor agonist heterocyclic compounds NOVARTIS AG (CH) 2017-03-28 — — US disclosed
US-9604981-B2 IP receptor agonist heterocyclic compounds NOVARTIS AG (CH) 2017-03-28 — — US disclosed
US-20140378463-A1 IP receptor agonist heterocyclic compounds NOVARTIS AG (CH) 2014-12-25 — — US disclosed
US-20140243346-A1 IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS NOVARTIS AG (CH) 2014-08-28 — — US disclosed
US-20140243346-A1 IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS NOVARTIS AG (CH) 2014-08-28 — — US disclosed
US-8754085-B2 Pyrido[2,3-b]pyrazine compounds useful as IP receptor agonist NOVARTIS AG (CH) 2014-06-17 — — US disclosed
US-8754085-B2 Pyrido[2,3-b]pyrazine compounds useful as IP receptor agonist NOVARTIS AG (CH) 2014-06-17 — — US disclosed
US-20130210704-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. (US) 2013-08-15 — — US disclosed
US-20130184282-A1 IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS NOVARTIS AG (CH) 2013-07-18 — — US disclosed
US-20130102611-A1 IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS NOVARTIS AG (CH) 2013-04-25 — — US disclosed
US-20120077781-A1 FLAVIN DERIVATIVES GADWOOD ROBERT (US) 2012-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378463-A1 IP receptor agonist heterocyclic compounds PTGIR, GPR68, ACVR1 CYP1A2 1577/4885GAA 4695/4885ALDH1A1 2952/4885
US-10647747-B2 Cyclosporin derivatives and uses thereof FKBP5, FKBP1B, MALT1 CYP1A2 805/4885GAA 1421/4885ALDH1A1 2350/4885
US-20130210704-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 CYP1A2 1223/4885GAA 1510/4885ALDH1A1 2376/4885
US-20140243346-A1 IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS PTGIR, ACVR1, PTGFR CYP1A2 2264/4885GAA 4682/4885ALDH1A1 2869/4885
US-20130102611-A1 IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS PTGIR, ACVR1, PTGFR CYP1A2 2264/4885GAA 4682/4885ALDH1A1 2869/4885
US-20120077781-A1 FLAVIN DERIVATIVES BLVRB, FLAD1, FDPS CYP1A2 465/4885GAA 3812/4885ALDH1A1 807/4885
US-20180105558-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 CYP1A2 1223/4885GAA 1510/4885ALDH1A1 2376/4885
US-20130184282-A1 IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS PTGIR, GPR68, ACVR1 CYP1A2 2071/4885GAA 4722/4885ALDH1A1 3576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.